Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1B |
| 2 |
Merck
MRK
|
+$986M |
| 3 |
Abbott
ABT
|
+$969M |
| 4 |
NVIDIA
NVDA
|
+$967M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$814M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.46B |
| 2 |
Morgan Stanley
MS
|
+$910M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$909M |
| 4 |
Coca-Cola
KO
|
+$745M |
| 5 |
Arista Networks
ANET
|
+$692M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.51% |
| 2 | Technology | 19.42% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.08% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Timken Company
TKR
$9.23B
| $1.5M | ﹤0.01% |
16,436
+5,785
| +54% | +$456K |
|
1452
American Eagle Outfitters
AEO
$3.04B
| $1.49M | ﹤0.01% |
+126,668
| New | +$1.58M |
|
1453
Kodiak Gas Services
KGS
$5.97B
| $1.49M | ﹤0.01% |
+91,853
| New | +$1.47M |
|
1454
Associated Banc-Corp
ASB
$6.03B
| $1.48M | ﹤0.01% |
91,321
| – | – |
|
1455
GDS Holdings
GDS
$6.64B
| $1.48M | ﹤0.01% |
134,666
-43,600
| -24% | -$579K |
|
1456
Harmony Biosciences
HRMY
$2.25B
| $1.47M | ﹤0.01% |
41,720
-18,311
| -31% | -$632K |
|
1457
Shore Bancshares
SHBI
$828M
| $1.45M | ﹤0.01% |
125,442
-57,599
| -31% | -$706K |
|
1458
Ocular Therapeutix
OCUL
$1.88B
| $1.45M | ﹤0.01% |
280,874
-26,234
| -9% | -$156K |
|
1459
W.P. Carey
WPC
$16.5B
| $1.45M | ﹤0.01% |
21,881
-932,832
| -98% | -$64.9M |
|
1460
Qfin Holdings
QFIN
$1.65B
| $1.44M | ﹤0.01% |
83,332
+59,894
| +256% | +$1.01M |
|
|
THRX
1461
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $1.43M | ﹤0.01% |
153,673
+42,061
| +38% | +$414K |
|
1462
Century Aluminum
CENX
$4.68B
| $1.43M | ﹤0.01% |
164,361
-2,769
| -2% | -$24.1K |
|
1463
Teradata
TDC
$3.17B
| $1.43M | ﹤0.01% |
26,825
-28,417
| -51% | -$1.28M |
|
1464
Teledyne Technologies
TDY
$31.7B
| $1.43M | ﹤0.01% |
3,477
+470
| +16% | +$194K |
|
1465
JELD-WEN Holding
JELD
$150M
| $1.42M | ﹤0.01% |
81,120
-291,820
| -78% | -$4.07M |
|
|
LOVE
1466
LoveSac
LOVE
$269M
| $1.41M | ﹤0.01% |
52,500
+33,100
| +171% | +$844K |
|
|
GRMN
1467
Garmin
GRMN
$59.2B
| $1.41M | ﹤0.01% |
13,533
+1,695
| +14% | +$173K |
|
1468
Nurix Therapeutics
NRIX
$2.55B
| $1.41M | ﹤0.01% |
140,890
+70,361
| +100% | +$718K |
|
1469
Phathom Pharmaceuticals
PHAT
$684M
| $1.4M | ﹤0.01% |
+98,013
| New | +$1.13M |
|
1470
Alexandria Real Estate Equities
ARE
$8.76B
| $1.4M | ﹤0.01% |
12,296
-110,508
| -90% | -$13.2M |
|
1471
Hartford Financial Services
HIG
$38.9B
| $1.38M | ﹤0.01% |
19,203
-1,388
| -7% | -$97.5K |
|
1472
Coherus Oncology
CHRS
$230M
| $1.38M | ﹤0.01% |
323,539
+232,368
| +255% | +$1.37M |
|
1473
Truist Financial
TFC
$64.5B
| $1.37M | ﹤0.01% |
45,296
-12,415,021
| -100% | -$386M |
|
1474
Vanda Pharmaceuticals
VNDA
$319M
| $1.37M | ﹤0.01% |
+208,389
| New | +$1.34M |
|
1475
Omega Healthcare
OHI
$14.5B
| $1.36M | ﹤0.01% |
44,330
-30,639
| -41% | -$885K |
|
Similar funds
Wellington Management Group's Q2 2023 Portfolio in Review
As of Q2 2023, Wellington Management Group held 2,099 positions worth $527B, up 4.5% from $505B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Wellington Management Group's Q2 2023 filing shows 119 new, 718 increased, 815 reduced and 304 closed positions. Its largest new stake was Kenvue: 10,602,707 shares worth $280M. The largest sale was Eli Lilly, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Financials.
- Wellington Management Group's largest Q2 2023 buy was Kenvue: 10,602,707 shares worth $280M.
- Wellington Management Group added most to Gilead Sciences in Q2 2023, an estimated $1B increase.
- Wellington Management Group's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $2.46B.
- Wellington Management Group fully exited Syneos Health, Inc. Class A Common Stock in Q2 2023, selling an estimated $267M.
- Wellington Management Group's ten largest holdings make up 20% of its $527B portfolio in Q2 2023.
- Wellington Management Group opened 119 new positions and closed 304 in Q2 2023.
- Wellington Management Group's portfolio value rose 4.5% quarter-over-quarter to $527B.
Based on Wellington Management Group's 13F filing for Q2 2023, filed 14 Aug 2023.